FDA To Pull Immucor's Biologics License
The U.S. Food and Drug Administration plans to revoke the biologics license of medical device maker Immucor Inc. in relation to an investigation into some of the company's blood reagents, Immucor...To view the full article, register now.
Already a subscriber? Click here to view full article